17 May 2022 - Teva Canada welcomes the recently announced public formulary coverage for Ajovy (fremanezumab) by Ontario, British Columbia, ...
3 May 2022 - Boehringer Ingelheim is pleased to announce that Ofev (nintedanib), is now available for public reimbursement in Quebec, ...
21 April 2022 - Having access to an additional treatment option offers hope for Canadian adult AML patients with relapsed ...
28 February 2022 - The ALS Society of Canada Cana today marks Rare Disease Day 2022 by calling on the ...
24 February 2022 - Private insurance coverage across Canada exceeds 90%. ...
28 January 2022 - Lilly Canada is pleased to announce that as of 31 January 2022, Baqsimi (glucagon nasal powder) ...
12 October 2021 - An important flaw in the funding approach used by Canada’s public drug plans is highlighted by the ...
24 September 2021 - Ontario is now providing coverage for Trikafta, the latest and most effective treatment option for cystic fibrosis ...
20 August 2021 - An Ontario teen living with Cystic Fibrosis and her mother are hoping to shine a light ...
25 May 2021 - Dupixent is the only biologic medicine approved by Health Canada to treat moderate to severe atopic dermatitis. ...
28 April 2021 - Additional provincial coverage expected to follow. ...
18 March 2021 - Ontarians with cystic fibrosis made an emotional plea to Premier Ford this week in a video that ...
19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...
10 December 2020 - The first vaccines will go to health care workers at long-term care homes and other high-risk ...
8 October 2020 - Lutathera is the first and only therapeutic radiopharmaceutical approved by Health Canada for the treatment of GEP-NETs. ...